Two University of Nebraska Medical Center faculty members are collaborating on a $32 million grant to speed up the development of long-acting medicine for malaria, tuberculosis prevention and a cure for hepatitis C.
“We’re very excited to be apart of this and we’re very excited Nebraska is apart of this consortium that’s maybe going to make a big impact on global health,” Professor of Medicine Susan Swindells tells KLIN News.
They’re part of a five-year grant called LONGEVITY.
Dr. Swindells says UNMC will receive $2.7 million for the project.
Swindells added the diseases are associated with poverty in low-income countries.
“The spread is fueled because they affect poor people who have substandard housing, overcrowding, poor sanitation and lack of access to healthcare,” she says. “This fuels the spread of many infectious diseases.”
Swindells says the consortium is working to pre-emptively address common barriers encountered when developing new therapies, spanning product development, clinical testing, and eventually, wide-spread access to the medication.